BCL2L1 and cancer: Similarly, the Bcl-xl targeting miRNAs like miR-608, miR-133a, miR-491-5p, let-7, and miR-491 have been reported to be downregulated in different cancers, causing aggressive cancer progression [214,215,216,217,218].